PEDIATRIC CELL THERAPY & GROWTH-SAFE RADIOTHERAPY

Advanced Childhood Cancer Care in China

Childhood cancers—including pediatric leukemia, neuroblastoma, and brain tumors—demand treatments that achieve complete cure while strictly protecting a growing child’s organs, intellect, and physical development. China operates the world’s highest-volume pediatric CAR-T and bone marrow transplant centers, alongside child-friendly proton radiation that protects growing tissues.

  • Relapsed or Refractory Pediatric Leukemia (ALL & AML)
  • High-Risk Neuroblastoma, Wilms Tumor, and Medulloblastoma
  • Children Requiring Radiation Who Need Protection for Brain & Growth
  • Dedicated Pediatric Hematology-Oncology Units with Sterile Suites
  • Over 90% Complete Remission Rates with Pediatric CAR-T Cells
  • Family-Centered Care with Dedicated English Bedside Navigators

PEDIATRIC CELLULAR, PROTON & MULTIDISCIPLINARY CARE

Key Childhood Cancer Treatments in China

High-remission pediatric CAR-T cell therapy, child-safe proton beam radiation, and half-matched bone marrow transplants.

Pediatric CAR-T Cell Therapy

Gentle, living cell therapy achieving over 90% complete remission in relapsed and refractory pediatric acute lymphoblastic leukemia (ALL).
Learn More

Child-Safe Proton Particle Therapy

Pinpoint proton beams with zero exit dose, protecting growing bones, brain development, vision, and endocrine organs from radiation harm.
Learn More

Half-Match Pediatric Transplant

Using the Beijing Protocol, either parent can serve as an immediate stem cell donor without waiting months for an unrelated donor registry.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Childhood Cancer Care

A family-first clinical pathway connecting international children directly with China’s top national pediatric medical centers.

China’s national pediatric medical centers treat the world’s largest cohorts of childhood hematologic and solid tumors. Pediatric CAR-T cellular therapy programs in Beijing and Shanghai have treated thousands of children from around the world, achieving unmatched complete remission rates in relapsed acute lymphoblastic leukemia.

For pediatric brain and spinal tumors, national proton centers offer child-tailored particle therapy that virtually eliminates long-term cognitive and hormonal deficits. Hospitals provide welcoming, family-centered private rooms where parents can stay with their child, supported by bilingual clinical coordinators and transparent public billing.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload pathology reports, biomarker NGS profiles, and imaging scans through our confidential clinical intake portal.

02. Remote MDT Review

National Clinical Research Center oncology boards evaluate eligibility, target expression, and formulate a customized protocol.

03. Visa & Admission

Receive official hospital medical invitation letters, transparent pricing schedules, and expedited department admission.

04. Treatment & Follow-up

Inpatient cellular or particle therapy in ISO-GMP cleanrooms with dedicated bilingual escorts and remote post-discharge care.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Childhood Cancer patients considering advanced treatment in China.

Children’s developing tissues and organs are extremely sensitive to radiation. Proton therapy stops inside the tumor with no exit dose, preventing long-term damage to learning, vision, hearing, and growth.
Clinical trials and real-world results in China consistently show complete remission rates exceeding 90% for relapsed and refractory pediatric B-ALL.
Yes. Accredited pediatric units provide private rooms with parent accommodations so families can remain together throughout treatment and recovery.
Pediatric oncology teams prioritize international children, completing comprehensive case evaluations and issuing clinical recommendations within 24 to 48 hours.

PEDIATRIC ONCOLOGY CLINICAL ASSESSMENT

Request a Confidential Case Review for Childhood Cancer

Share your child’s medical history, bone marrow/biopsy records, and imaging for an expedited compassionate review by our senior pediatric oncology board.

    Childhood Cancer